Ceo
Current-Developed a platform based on QAOA and GBS for protein pruning and binding, and used this platform for binding work around SARS-CoV-2 research extensively, including for immune protein interactions such as the SARS-CoV-2 spike and SP-D -Deployed this platform on various cloud and quantum cloud systems, ranging from superconducting, ion trap, photonic, and.